Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quintiles, Scottish Health Boards In Clinical Research Pact | Contract Pharma
Breaking News

Quintiles, Scottish Health Boards In Clinical Research Pact

Aims to improve health outcomes

Quintiles has entered a strategic partnership with four teaching health boards in Scotland as part of its Prime Site program to accelerate development of new and more effective medicines. The alliance aims to increase access to clinical trials for both patients and investigators, and accelerate the collection of safety and efficacy data of investigational therapies.
 
Quintiles will work with NHS Scotland’s four university-based academic research centers in Aberdeen, Dundee, Edinburgh and Glasgow. These sites have broad therapeutic expertise and a reputation for high-quality research. Quintiles will introduce new technology that uses electronic health records to improve the identification of patients for potential inclusion in clinical research.
 
“Scotland has a significant burden of disease and a huge need to speed the development of new therapies that will help people live healthier lives,” said Lindy Jones, global head of Integrated Site Services, Quintiles. “We have a successful track record of collaboration with Scottish government and health care organizations. This partnership will further enhance our ability to recruit patients and investigators – two groups critical to an efficient and effective drug development process.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters